Concourse Financial Group Securities, Inc. Arbutus Biopharma Corp Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$3.12 - $4.56 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$2.52 - $3.63 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$2.26 - $2.92 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$1.69 - $2.54 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$1.9 - $2.27 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$1.9 - $2.27 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$2.24 - $3.06 $0 - $0
Q1 2023 May 15, 2023	BUY	$2.23 - $3.1 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$1.91 - $2.85 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$1.88 - $2.88 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$1.98 - $3.17 $0 - $0
Q1 2022 May 09, 2022	BUY	$2.42 - $3.98 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$3.11 - $4.61 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$2.65 - $4.62 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$2.5 - $3.51 $0 - $0
Q1 2021 May 13, 2021	BUY	$3.14 - $4.84 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$2.76 - $4.97 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$1.75 - $6.2 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$0.91 - $2.36 $0 - $0
Q1 2020 May 13, 2020	BUY	$1.01 - $3.42 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$0.87 - $2.89 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$1.34 - $2.4 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$1.46 - $4.44 $0 - $0
Q1 2019 May 15, 2019	BUY	$3.41 - $4.57 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$3.5 - $9.66 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$7.85 - $12.35 $0 - $0

Others Institutions Holding ABUS

# of Institutions

155

Shares Held

99.5M

Call Options Held

2.31M

Put Options Held

525K

Morgan Stanley New York, NY

21.7M
Shares

$69.2 Million
0.01% of portfolio
Whitefort Capital Management, LP New York, NY

12.9M
Shares

$41 Million
26.34% of portfolio
Black Rock Inc. New York, NY

11.6M
Shares

$36.9 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

8.92M
Shares

$28.5 Million
0.0% of portfolio
Two Seas Capital LP Rye, NY

8.39M
Shares

$26.8 Million
10.86% of portfolio

View Full List

About Arbutus Biopharma Corp

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $478M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

More about ABUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account